RPTX — Repare Therapeutics Balance Sheet
0.000.00%
Last trade - 00:00- $91.99m
- -$20.61m
- $53.48m
- 46
- 32
- 73
- 49
Annual balance sheet for Repare Therapeutics, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Cash and Equivalents | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 334 | 342 | 344 | 224 | 153 |
| Net Total Receivables | 6.16 | 3.23 | 4.32 | 15.3 | 12.3 |
| Prepaid Expenses | |||||
| Total Current Assets | 347 | 351 | 354 | 244 | 171 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 8.62 | 13.1 | 9.6 | 7.54 | 4.22 |
| Long Term Notes Receivable | |||||
| Other Long Term Assets | |||||
| Total Assets | 357 | 369 | 364 | 254 | 177 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 11 | 35.1 | 78.6 | 39.1 | 25.3 |
| Total Long Term Debt | |||||
| Total Debt | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 70.3 | 80.3 | 84.6 | 41.8 | 25.4 |
| Non Redeemable Preferred Stock | |||||
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Other Equity | |||||
| Total Equity | 287 | 288 | 280 | 212 | 151 |
| Total Liabilities & Shareholders' Equity | 357 | 369 | 364 | 254 | 177 |
| Total Common Shares Outstanding |